Brower Piven Encourages Investors Who Have Losses in Excess of $50,000 From Investment in Repros Therapeutics, Inc. to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Before the October 6, 2009 Lead Plaintiff Deadline